ExpreS2ion Biotechnologies – Presentation of Q3 Quarterly Results
Watch live when the CEO of ExpreS2ion Biotechnologies, Bent Frandsen and the CFO, Keith Alexander presents the Q3 quarterly financial results. During the event it will be possible to ask questions.
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines. Currently the company is developing vaccines against Covid-19, breast cancer and Influenza.
Recently the company announced a subscription of their TO5 warrant program at 97.5%. This means the share capital of the company has risen by 6% and SEK 44.4 Millions before costs with the purpose of financing the continued development of their pipeline.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR / Corporate Visibility subscription agreement.